5 completed, 1 active not recruiting, 1 enrolling by invitation. 7 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Active not recruiting 1, Enrolling by invitation 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Enrolling by invitation 1 |
Follow tapinarof: new trials by email Literature Review of tapinarof trials Research Report on tapinarof
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety and Efficacy of Tapinarof in Adults With Palmoplantar Keratoderma Tapinarof - Palmoplantar Keratoderma | Phase 2 | Active not recruiting | Indiana University | 6 | 2024-10-30 | 2026-06-23 |
| Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant) Betamethasone dipropionate 0.05%, Tapinarof - ICD10 Code L40.9 for Psoriasis | Phase 2 / Phase 3 | Enrolling by invitation | Wake Forest University Health Sciences | 40 | 2024-07-15 | 2026-08-04 |
| A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD) GSK2894512 1% Cream, GSK2894512 0.5% Cream, Vehicle cream - Dermatitis, Atopic | Phase 2 | Completed | GlaxoSmithKline | 247 | 2015-12-01 | 2017-11-20 |
| A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis GSK2894512 1% Cream, GSK2894512 0.5% Cream, Vehicle cream - Psoriasis | Phase 2 | Completed | GlaxoSmithKline | 227 | 2015-11-23 | 2017-11-13 |
| A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks WBI-1001 - Psoriasis | Phase 2 | Completed | Welichem Biotech Inc. | 61 | 2010-01-01 | 2012-12-20 |
| Non-steroid, Atopic Dermatitis Phase IIb 12-week Trial; Topical WBI-1001 Cream WBI-1001 - Dermatitis, Atopic | Phase 2 | Completed | Welichem Biotech Inc. | 148 | 2009-11-01 | 2011-06-13 |
| Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis WBI-1001 - Dermatitis, Atopic | Phase 1 / Phase 2 | Completed | Welichem Biotech Inc. | 36 | 2008-03-01 | 2009-02-05 |
Dermatitis, Atopic (3) · Psoriasis (2) · Skin Diseases (2) · Eczema (1) · Keratoderma, Palmoplantar (1)
Welichem Biotech Inc. (3) · GlaxoSmithKline (2) · Indiana University (1) · Wake Forest University Health Sciences (1)
Canada (4) · United States (4) · Japan (2)
David Rosmarin, MD (1) · Liren Tang, Ph.D (1) · Robert Bissonnette, MD (1) · Robert Bissonnette, MD, MSc (1) · Steven R Feldman, MD, PhD (1)